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This report describes hyperkalemia-induced failure of
atrial capture associated with preservation of ventricular
pacing in a patient with a dual-chamber (DOD) pace-
maker. This differential effect on atrial and ventricular
excitability during cardiac pacing correlates with the
Hyperkalemia increases the ventricular excitability thresh-
old and occasionallycauses failureof an artificialventricular
pacemaker (1-3). In this report, we describe hyperkalemia-
induced failure of atrial capture associated with preservation
of ventricularpacing ina patient with a dual-chamber (DOD)
pulse generator. This differential effect correlates with ex-
perimental and clinical observations showing that the atrial
myocardium is more sensitive to hyperkalemia than is the
ventricular myocardium (4- 6).
Case Report
A 75 year old man presented with intermittent atrioven-
tricular (AV) block and received an Intermedics Cosmos
unipolar DOD pulse generator (model 283-0 I) implanted
transvenously. He was also being treated for coronary artery
disease, congestive heart failure and ventricular arrhythmias
with digoxin, furosemide, isosorbide dinitrate , captopril and
quinidine. The long-termpacing thresholds were determined
8 weeks after pacemaker implantation. The atrial threshold
was 2.7 Y at 0.05 ms pulse width. and the ventricular
threshold was 2.7 Y at 0.10 ms pulse width. These pacing
thresholds remained unchanged over the next 10 months.
The pulse generator was programmedas follows: lower rate.
70 pulses/min: upper, 110pulses/min; atrioventricular (AY)
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well known clinical and experimental observation that
the atrial myocardium is more sensitive to hyperkalemia
than is the ventricular myocardium.
(J Am Coll Cardiol /987;10:467-9)
delay. 200 ms; atrial output. 2.7 Y at 0.6 ms; ventricular
output. 5.4 Y at 0.3 ms: atrial sensitivity. 0.4 mY; ven-
tricular sensitivity, 4 mY; postventricular atrial refractory
period. 290 rns; and ventricular refractory period, 200 rns.
About a year after pacemaker implantation, the patient
was hospitalized with recurrent congestive heart failure and
pneumonia. The electrocardiogram (ECG) showed normal
DOD pacing and sensing. The atrial and ventricular pacing
thresholds were unchanged. Pertinent laboratory investi-
gations on admission were as follows: serum potassium, 4.5
mEq/liter; blood urea nitrogen (BUN), 38 mg/dl; creatinine.
2 mg/dl; digoxin level, 1.7 ng/ml; and quinidine level, 4.3
p,g/ml. The patient's condition improved with diuretics and
the pneumonia responded to erythromycin.
Effects of hyperkalemia. Twelve days after admission
he became hypotensive with a blood pressure of 70/40 mm
Hg. The ECG revealed no spontaneous atrial activity, in-
effectual atrial stimuli and widening of the paced QRS com-
plex. Atrial capture remained unsuccessful even with a max-
imal atrial output of 8. I Y and 1.0 ms pulse width (Fig.
I). The AY delay was programmed to 300 ms to exclude
latency of atrial depolarization. Temporary reprogramming
to the atrial-inhibited (AAI) mode revealed ineffectual atrial
pacing stimuli. no spontaneous atrial or ventricular depo-
larizations and prolonged ventricular asystole. The threshold
for ventricular pacing was 5.4 Y at 0.2 ms pulse width, and
the ventricular output of the pulse generator was therefore
reprogrammed to 5.4 V and 0.6 ms pulse width. At the
time. pertinent laboratory investigations revealed: serum so-
dium. 127 mEq/liter: potassium, 6.3 mEq/liter; Co2 , 34
mEq/liter; chloride. 80 mEq/liter; BUN, 69 mg/dl: creati-
nine. 4.4 mg/dl; serum quinidine. 6.3 p,g/ml; and serum
digoxin. 4.7 ng/ml. Five units of regular insulin were ad-
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Figure 1. ECG (leads VI to V6) showing hyperkalemia-induced
failure of atrial capture during dual-chamber (DOD) pacing. The
paced QRS complex is widened to 0.36 second. Pacemaker vari-
ables: lower rate, 70 pulses/min; atrioventricular delay, 200 ms;
atrial output, 8.1 V at 1.0 ms pulse width; and ventricular output,
5.4 V at 0.6 ms pulse width.
Figure 2. ECG (leads V 1 to V6) showing restoration of atrial
capture a few minutes after treatment of hyperkalemia. The interval
from the onset of the atrial stimulus to the isoelectric segment of
the PR interval measuresapproximately0.22 second and represents
delay in intraatrial conduction. The duration of the paced QRS
complex has shortened to 0.30 second. Pacemaker variables: lower
rate, 70 pulses/min; atrioventricular interval, 300 rns; atrial output,
8.1 V at 1.0 ms pulse width; ventricular output, 5.4 volts at 0.6
ms pulse width.
Figure 3. ECG (leads V) to V6) recorded 24 hours after Figures
1 and 2 when the serum potassium was normal. The interval from
the onset of the atrial stimulus to the isoelectric segment of the
PR interval has shortened to 0.16 second and the paced QRS
complex exhibits further shortening to 0.24 second. Pacemaker
variables: lower rate, 90 pulses/min (increased from 70 because
of congestive heart failure and ventricular ectopic activity); atrio-
ventricular interval, 300 ms; atrial output, 5.4 V at 0.6 ms pulse
width; ventricular output, 5.4 V at 0.6 ms pulse width.
ministered intravenously followed by 50 cc of 50% glucose,
also intravenously. A few minutes after the glucose infusion,
the ECG revealed successful atrial capture (Fig. 2) at which
point the blood pressure immediately increased to 100170
mm Hg. At that time the threshold for atrial pacing was 5.4
V at 0.3 ms. The patient was treated with sodium polysty-
rene sulfonate (Kayexalate) enemas. The next day, when
the serum potassium was normal, the ECG showed normal
AV sequential pacing with a shorter duration of the paced
P wave and QRS complex (Fig. 3). The threshold for atrial
pacing was 2.7 Vat 0.05 ms pulse width and the ventricular
threshold was 2.7 V at 0.10 ms pulse width. Subsequent
pacemaker function has remained normal and the thresholds
have also remained constant.
Discussion
Hyperkalemia depresses impulse conduction and myo-
cardial excitability (1-8). The myocardium is far more sen-
sitive to the effect of hyperkalemia than are the specialized
fibers of the sinoatrial node and the bundle of His (5-7).
The atrial myocardium is also more sensitive to hyperka-
lemia than is the ventricular myocardium (4-7). In the atria,
hyperkalemia causes prolongation of the PR interval and
the P wave gradually flattens until it disappears from the
surface ECG, when "sinoventricular" conduction may con-
tinue from the sinoatrial node to the ventricles by way of
specialized atrial pathways (4-7).
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Effect of hyperkalemia on the pacing threshold. The
effect of potassium on the excitability threshold of atrial
and ventricular myocardium is not clearly defined. Failure
of impulse propagation due to depression of intraatrial or
intraventricular conduction may explain the failure of pace-
maker capture in hyperkalemia, The pacing threshold may
also be influenced by local changes in conduction near the
pacing electrodes (9), Indeed, during ventricular pacing,
hyperkalemia may cause latency or an increase in the in-
terval between the ventricular stimulus and the onset of the
paced QRS complex (first degree ventricular pacemaker exit
block), sometimes progressing to Wenckebach (type I) sec-
ond degree pacemaker exit block or even complete exit block
(3,10,11),
As far as atrial pacing is concerned, Bashour et al. (12)
reported a single case of hyperkalemia-induced (K = 6,8
mEq/liter) latency (prolongation of the interval from the
atrial stimulus to the paced P wave) that decreased after
treatment of hyperkalemia, We could not find any previous
report of hyperkalemia-induced unresponsiveness of the atria
to pacing stimuli in humans, Indeed, total unresponsiveness
to ventricular stimuli (that is, complete ventricular pace-
maker exit block) has been reported in only three cases of
hyperkalemia with plasma potassium levels of 6.6,6.9 and
7.1 mEq/liter, respectively (1-3). The modest elevation of
serum potassium in these cases and ours suggests that nu-
merous other metabolic variables may influence the sensi-
tivity of cardiac tissue to hyperkalemia. These include other
electrolytes, acid-base balance (13), oxygen saturation (14),
the rate of change of plasma potassium level, the intracel-
lular-extracellular potassium gradient (15,16) and the etiol-
ogy and severity of heart disease (7). For this reason, the
cardiac manifestations of hyperkalemia in the clinical setting
tend to occur at much lower potassium levels than the levels
measured during the experimental infusion of potassium
(1,6,7). The high serum digoxin and slightly raised quini-
dine levels in our patient probably contributed little to the
elevation of pacing thresholds because of the immediate and
dramatic restoration of effectual atrial pacing with the treat-
ment of hyperkalemia. In addition, previous studies suggest
that digitalis does not increase the pacing threshold (14,15,17).
Clinical implications. Our observations have clearly
demonstrated the differential effect of hyperkalemia on the
excitability threshold of the atria and ventricles in a patient
with a DDD pacemaker. In patients susceptible to hyper-
kalemia, the relatively sudden occurrence of failure of atrial
pacing with the preservation of ventricular pacing by a DDD
pacemaker should not be misinterpreted as a primary or
technical pacemaker problem. In patients with a DDD pace-
maker, poor left ventricular function and hyperkalemia, the
loss of atrial contribution to ventricular filling may lead to
hemodynamic deterioration that could be potentially fatal if
not promptly diagnosed as being secondary to hyperkalemia
and treated accordingly.
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